AHI1 |
Q8N157
|
Abelson helper integration site 1
|
|
1.1E-25 |
0.513 |
0.846 |
AKT1 |
P31749
|
AKT serine/threonine kinase 1
|
Kinase
|
0.98 |
0.311 |
0.962 |
ATM |
Q13315
|
ATM serine/threonine kinase
|
Kinase
|
5.6E-47 |
0.374 |
0.885 |
BAX |
Q07812
|
BCL2 associated X, apoptosis regulator
|
Signaling
|
0.32 |
0.417 |
0.885 |
BCL2 |
P10415
|
BCL2 apoptosis regulator
|
Signaling
|
0.56 |
0.291 |
0.885 |
BRAF |
P15056
|
B-Raf proto-oncogene, serine/threonine kinase
|
Kinase
|
1.00 |
0.319 |
0.846 |
BRD4 |
O60885
|
bromodomain containing 4
|
Epigenetic regulator
|
1.00 |
0.446 |
0.885 |
CASP3 |
P42574
|
caspase 3
|
Enzyme
|
0.10 |
0.351 |
0.923 |
CCND1 |
P24385
|
cyclin D1
|
Enzyme modulator
|
0.89 |
0.344 |
0.923 |
CCR7 |
P32248
|
C-C motif chemokine receptor 7
|
G-protein coupled receptor
|
5.8E-02 |
0.443 |
0.769 |
CD274 |
Q9NZQ7
|
CD274 molecule
|
Receptor
|
1.9E-02 |
0.324 |
0.923 |
CD28 |
P10747
|
CD28 molecule
|
|
0.36 |
0.436 |
0.885 |
CD40LG |
P29965
|
CD40 ligand
|
Signaling
|
0.72 |
0.414 |
0.846 |
CD44 |
P16070
|
CD44 molecule (Indian blood group)
|
|
2.4E-07 |
0.363 |
0.962 |
CDK2 |
P24941
|
cyclin dependent kinase 2
|
Kinase
|
0.61 |
0.456 |
0.692 |
CDKN1B |
P46527
|
cyclin dependent kinase inhibitor 1B
|
|
0.62 |
0.409 |
0.769 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
CDKN2B |
P42772
|
cyclin dependent kinase inhibitor 2B
|
|
7.3E-03 |
0.417 |
0.769 |
CFLAR |
O15519
|
CASP8 and FADD like apoptosis regulator
|
Enzyme
|
1.00 |
0.485 |
0.846 |
CSF2 |
P04141
|
colony stimulating factor 2
|
Signaling
|
0.83 |
0.330 |
0.962 |
CTLA4 |
P16410
|
cytotoxic T-lymphocyte associated protein 4
|
|
0.94 |
0.369 |
0.923 |
CTNNB1 |
P35222
|
catenin beta 1
|
|
1.00 |
0.303 |
0.885 |
CXCR4 |
P61073
|
C-X-C motif chemokine receptor 4
|
G-protein coupled receptor
|
1.8E-02 |
0.362 |
0.923 |
DNMT3A |
Q9Y6K1
|
DNA methyltransferase 3 alpha
|
|
7.4E-39 |
0.445 |
0.846 |
DPP4 |
P27487
|
dipeptidyl peptidase 4
|
Enzyme
|
7.3E-09 |
0.420 |
0.808 |